Recent
treatment studies demonstrate that parents can improve on various aspects of their emotion socialization practices in the context of interventions that also target child behavioral problems [32, 73].
Not exact matches
Chicago, GenomeWeb — A new
study by researchers from Memorial Sloan Kettering Cancer Center has
demonstrated the predictive power of an AR - V7 protein expression test using Epic Sciences» non-EPCAM-based circulating tumor cell detection platform, which could help guide
treatment decisions for men with metastatic castration - resistant prostate cancer.
Lest common sense fail to convince readers that surgery is not a
treatment for a mental disorder, a Swedish
study published in 2011 found that over the long term, 324 people who had undergone sex - reassignment surgery
demonstrated an alarmingly high suicide rate and experienced considerably higher numbers of severe psychiatric problems than were present in the general population.
Some
studies have
demonstrated cytotoxicity of silver in wound repair and natural antimicrobials are being sought as alternative topical wound
treatments to silver.
Ironically, the above
study demonstrated that 3.7 % of hospitalized patients sustain an injury caused by medical
treatment; 69 % of these injuries were preventable and 14 % of these errors contributed to the death of the patient.
Sensory Integration (SI) is somewhat of an unknown in the medical arena, and understandably so — it is just recently that
studies are beginning to
demonstrate the true efficacy of
treatment.
«Freezing hunger - signaling nerve may help ignite weight loss: Pilot
study demonstrates safety of new weight - loss
treatment for mild - to - moderate obesity.»
A sensitivity analysis omitting the cluster - randomised
study (Ochola 2013) for which a design effect could not be calculated
demonstrated a similar positive
treatment effect (average RR 0.80, 95 % CI 0.71 to 0.89).
After early animal
studies demonstrated that the synthetic cannabis extract dronabinol improved respiratory stability, recent
studies in humans have explored the potential use of dronabinol as an alternative
treatment for sleep apnea.
In a
study featured in the December issue of The Journal of Nuclear Medicine, Australian researchers
demonstrate that PET scans can identify which of these prostate cancer patients would benefit from salvage radiation
treatment (SRT).
The
study demonstrates that PSMA PET can independently predict
treatment response to SRT.
Previous
studies also
demonstrate that moderate hypo - fractionated radiation therapy (HRT), consisting of daily
treatment for one month using a larger dose per
treatment, provides a similar low risk of recurrence, and may even be lower with HRT than CRT.
Previously,
studies have consistently
demonstrated that conventionally fractionated high dose external beam radiation therapy (CRT), consisting of daily
treatment for two months, decreases prostate cancer recurrence, and improves metastasis - free survival.
To accurately test the hypothesis of a lower risk of recurrence with HRT, a new
study led by investigators at Brigham and Women's Hospital published in European Urology Focus, performed a systematic review and meta - analysis, pooling available data, to assess whether an improved risk of recurrence could be
demonstrated using HRT compared with CRT, in addition to assessing the relative impact of these two
treatments on bladder and rectal function.
«This
study demonstrates the value of using the SEER database to analyze factors associated with surgery as a
treatment for localized pancreatic cancer in a large number of patients over a prolonged period of time,» says Dr. Kim, who is also Chief Medical Officer of UH Seidman Cancer Center and the Charles Hubay Professor at Case Western Reserve School of Medicine.
Treatment implications were examined in a series of human
studies that
demonstrated similar reductions in the microbiome in participants suffering from both major depression and bipolar disorder.
«This
study demonstrates that targeted fusion - guided biopsy could significantly enhance our ability to identify patients with high - risk prostate cancers that need more aggressive
treatment,» says lead author Mohummad Minhaj Siddiqui, MD, assistant professor of surgery at the University of Maryland School of Medicine and director of urologic robotic surgery at the University of Maryland Marlene and Stewart Greenebaum Cancer Center.
The
study was not powered to
demonstrate a
treatment effect on kidney function, but there was no evidence of a benefit associated with bosutinib compared with placebo over the 2 - year
treatment period.
Findings from a
study in animals appear to
demonstrate that temporarily blocking a type of protein, called type I interferon, can restore immune function and speed up viral suppression during
treatment with anti-viral drugs for people with chronic infection of the virus that causes AIDS.
The positive effects of this therapy have been well proven in major
studies, and the substance has also
demonstrated its effectiveness in the
treatment of chronic migraines in clinical practice.
However, a new
study conducted at Manchester Royal Eye Hospital and published in the American Journal of Ophthalmology,
demonstrates high levels of undiagnosed anxiety and depression persisting in patients receiving
treatment, despite their improved visual outcomes.
Published in Nature Medicine on May 1, 2017, the
study demonstrates chronic ischemic hypoxia (lack of blood and oxygen) after spinal cord injury and how blood flow plays a key role in the cause and
treatment of motor disorders.
The researchers suggest that their
study demonstrates the potential of these non-toxic therapies to contribute to current cancer
treatment regimens and significantly improve the outcome of patients with advanced metastatic cancer.
«Our results provide a large body of evidence
demonstrating that the harmine drug class can make human beta cells proliferate at levels that may be relevant for diabetes
treatment,» said senior
study author Andrew Stewart, MD, Director of the Diabetes, Obesity and Metabolism Institute at the Icahn School of Medicine.
«Other
studies have looked at racial disparities in
treatment and still others have focused on racial differences in survival rates of cancer patients, but our research attempted to go further by
demonstrating the impact of race - based inequalities in cancer
treatment on survival rates of black colorectal cancer patients,» said James D. Murphy, MD, MS, assistant professor and chief of the Radiation Oncology Gastrointestinal Tumor Service at UC San Diego Moores Cancer Center.
In a previous
study, Nesha Burghardt, then a graduate student at New York University, and her colleagues
demonstrated that long - term SSRI
treatment impairs fear conditioning in rats.
«This
study demonstrates the value of testing lung cancer tissue for an ALK rearrangement, and it underscores the potential of cancer genomics to target cancer
treatments to each patient,» says the
study's senior author, Pasi A. Jänne, MD, PhD, who is the director of the Lowe Center for Thoracic Oncology of Dana - Farber.
«Prior research at Yale has
demonstrated that buprenorphine
treatment is highly effective in primary care, and this
study was designed in part to expand the reach of this
treatment to this critical ED patient population,» said Dr. Patrick O'Connor, professor of medicine and chief of general internal medicine at Yale School of Medicine.
«The
study demonstrates that controlled heating of one tumor can stimulate an immune response that attacks another tumor that has not had the heat
treatment,» said Steve Fiering, PhD, Norris Cotton Cancer Center researcher and professor of Microbiology and Immunology, and of Genetics at the Geisel School of Medicine at Dartmouth.
In the
study, analysis of patient samples
demonstrated that high LSC17 scores meant poor outcomes with current standard
treatment, even for patients who had undergone allogeneic stem cell transplantation.
The fda and the International Society for Stem Cell Research warn that no rigorous
studies have
demonstrated that such
treatments safely and effectively repair damaged connective tissue in people.
«Our
study is small, retrospective and all of the patients were located at a single medical center, but it
demonstrates that it's possible to use molecular diagnostics to identify subgroups of patients more likely to respond to a given
treatment,» said co-first author John Paul Shen, MD, senior clinical fellow and postdoctoral fellow.
Dr. Gonzalo Pizarro, one of the first authors on the
study, comments that «it has been possible to
demonstrate the beneficial and sustained effect of this acute
treatment thanks to the realization of advanced cardiac magnetic resonance analysis of almost all the patients in this clinical trial.»
The original, randomized, open label
study, which enrolled 20 outpatient men with cirrhosis and recurrent HE receiving standard - of - care (SOC)
treatment, had previously reported that a single FMT enema after antibiotic pretreatment improved cognitive function at Day 20 and reduced HE episodes and hospitalizations over the following 5 months compared with SOC.1 The long - term outcomes of this
study, which were presented today at The International Liver Congress ™ 2018 in Paris, France,
demonstrated sustained and statistically significant reductions in the number of HE episodes and hospitalizations as well as improvements in cognitive function over 1 year in the men who received FMT compared with the control group.
These case
studies — one case of recurrent and another with unresectable IVC - TT −
demonstrate that SABR can be an effective
treatment.
«We've
demonstrated that the concept works in retrospective
studies but this is really the first step in integrating the novel imaging and
treatment prospectively in patients.
Study demonstrates that mice can regrow hair follicles at wound sites; the finding could lead to
treatment for human hair loss
According to Saura, «this
study opens up new perspectives on therapeutic prevention and
treatment of Alzheimer's disease, given that we have
demonstrated that a gene therapy which activates the Crtc1 protein is effective in preventing the loss of memory in lab mice».
The
study adds to previous research by lead investigator Kalyani Sonawane, Ph.D.,
demonstrating that the drug
treatment, which combines two drugs in a single pill, known as fixed - dose combination, has several advantages over other approaches for adjusting blood pressure medication.
According to lead investigator Gerald Brock, MD, of the Department of Surgery, University of Western Ontario, London, ON, Canada, «Results from this
study demonstrate that long - term
treatment with T - sol successfully supplements testosterone levels in the majority of recipients.
«Although this
study demonstrates that atrasentan
treatment results in clinically significant albuminuria reduction with minimal fluid overload - related or cardiovascular side effects, a larger
study on hard renal and / or cardiac outcomes is needed to further support these findings,» said Dr. de Zeeuw.
Dr Justine Alford from Cancer Research UK, said: «This
study has
demonstrated it's possible to kill cancerous T - cells but importantly spare some healthy ones, opening up exciting new
treatment possibilities.
«These two
studies demonstrate that
treatment with tenofovir alafenamide is as effective and yet safer than
treatment with tenofovir disoproxil fumarate,» said Dr Maria Buti, Hospital General Universitari Vall d'Hebron, Barcelona, Spain, and lead author of one of the
studies.
In this
study, we
demonstrate how atomically dispersed ionic platinum (Pt2 +) on ceria (CeO2), which is already thermally stable, can be activated via steam
treatment (at 750 °C) to simultaneously achieve the goals of low - temperature carbon monoxide (CO) oxidation activity while providing outstanding hydrothermal stability.
This
study provides one of the first animal models to
demonstrate the long - term cognitive deficits resulting from a chemotherapeutic
treatment used in treating humans for breast cancer.
The newly published PLOS ONE
study assessed the long - term efficacy of the therapy and
demonstrated that a single gene therapy
treatment led to prolonged production of VNA in blood and protected the mice from subsequent exposures to C. botulinum toxin for up to several months.
It corroborates the findings of another NIAID - funded
study demonstrating that TMP - SMX
treatment resulted in better clinical outcomes than placebo for MRSA skin abscesses, and also upholds other findings that both clindamycin and TMP - SMX are equally beneficial in treating MRSA skin infections.
In conclusion, the results of the present
study demonstrate the effect of Hyssopus officinalis L. on chronic asthma, and may provide a novel therapeutic strategy for the
treatment of chronic asthma.
As the researchers put it: «Our
study demonstrates that the disparity in testing is not explained by differences in the doctors that black and white women see for their cancer
treatment.
Argonne researchers were able to
demonstrate the potential of using QMC in their
studies of ellipticine, a promising drug for uterine cancer
treatment.